The single most effective way to detect lung cancer early is an annual low-dose CT scan, which reduces lung cancer deaths by 20% in high-risk individuals. Early detection matters enormously here: when lung cancer is caught before it spreads beyond the lung, the five-year survival rate is 67%. Once it reaches distant organs like the brain, bones, or liver, that number drops to 12%.
Who Qualifies for Screening
The U.S. Preventive Services Task Force recommends annual screening with low-dose computed tomography (LDCT) for adults who meet all three of these criteria:
- Age: Between 50 and 80 years old
- Smoking history: At least 20 pack-years (for example, one pack a day for 20 years, or two packs a day for 10 years)
- Current or recent smoker: You either still smoke or quit within the past 15 years
Once you’ve been smoke-free for 15 years, annual screening is no longer recommended. Screening also stops if you develop a health condition that would make lung surgery unlikely or impractical, since the goal of catching cancer early is to treat it while it’s still treatable.
These guidelines leave out a large group of people who do get lung cancer, including never-smokers. If you have other significant risk factors (more on those below), talk with your doctor about whether screening makes sense for you even if you don’t check every box on the official criteria.
What the Screening Scan Is Like
A low-dose CT scan is fast and painless. You lie on a table while an X-ray machine takes detailed cross-sectional images of your lungs using a lower amount of radiation than a standard CT scan. The whole process takes just a few minutes, requires no injections or contrast dye, and you can go about your day immediately afterward.
The National Lung Screening Trial, a landmark study involving over 50,000 participants, found that people screened with LDCT had 20% fewer lung cancer deaths compared to those screened with standard chest X-rays. That’s because LDCT catches smaller nodules and abnormalities that a plain X-ray simply misses.
What Screening Costs
If you meet the eligibility criteria, you likely won’t pay anything out of pocket. Under the Affordable Care Act, private insurance plans must cover preventive screenings recommended by the USPSTF at no cost to you. Medicare Part B also covers annual LDCT screening with no coinsurance or deductible for beneficiaries aged 50 to 77 who meet the smoking history requirements.
There is one step Medicare requires before your first scan: a shared decision-making visit with your doctor. During this visit, your provider confirms your eligibility, discusses the benefits and limitations of screening, and provides smoking cessation resources if you’re still smoking. This visit is also covered.
Symptoms That Warrant Attention
Lung cancer often causes no symptoms in its earliest stages, which is exactly why screening matters so much. By the time symptoms appear, the cancer may have already grown or spread. Still, knowing what to watch for can prompt you to act sooner rather than later.
The symptoms most associated with lung cancer include a cough that doesn’t go away after three weeks, a long-standing cough that gets noticeably worse, pain when breathing or coughing, persistent breathlessness, and ongoing fatigue that doesn’t improve with rest. Persistent chest or shoulder pain is another signal, and one that people often attribute to something musculoskeletal.
A lesser-known sign is finger clubbing, where the tips of your fingers become rounder and the nails curve more than usual. This happens because of changes in blood oxygen levels and circulation, and while it has several possible causes, it’s one of the physical changes linked to lung cancer that people rarely think to mention to a doctor.
Risk Factors Beyond Smoking
Smoking causes the majority of lung cancer cases, but it’s not the only cause. Radon, a colorless and odorless gas that seeps into homes from the ground, is responsible for roughly 21,000 lung cancer deaths in the U.S. each year. The World Health Organization estimates that radon causes up to 15% of lung cancers worldwide.
You can test your home with an inexpensive kit from a hardware store. The EPA recommends taking action to reduce radon levels at or above 4 picocuries per liter (pCi/L), and suggests considering remediation even between 2 and 4 pCi/L. Mitigation typically involves installing a ventilation system beneath your home’s foundation, and it’s one of the most concrete steps you can take to lower your long-term lung cancer risk.
Occupational exposures also play a role. People who have worked with asbestos, arsenic, chromium, formaldehyde, or certain industrial chemicals face elevated risk, sometimes decades after the exposure occurred. If you spent years in construction, manufacturing, mining, or shipbuilding, that history is worth flagging to your doctor even if you’ve never smoked.
A family history of lung cancer, prior radiation therapy to the chest, and a personal history of chronic obstructive pulmonary disease (COPD) are additional factors that raise your risk profile.
What Blood Tests Can and Can’t Do
You may have seen headlines about blood-based cancer detection, sometimes called liquid biopsies. As of now, the FDA-approved liquid biopsy tests on the market are designed to guide treatment decisions for people who already have cancer. They profile tumors to help oncologists choose the right therapy. They are not approved or validated for screening healthy people or catching lung cancer in its early stages.
Several companies are developing blood-based screening tests that look for fragments of tumor DNA or specific protein signatures, but none have yet replaced LDCT as a proven early detection tool. For now, the low-dose CT scan remains the only screening method shown to reduce lung cancer deaths in clinical trials.
Making Screening Work for You
The biggest barrier to early detection isn’t technology. It’s participation. Fewer than 6% of eligible Americans actually get screened for lung cancer each year, a rate far lower than for breast or colon cancer screening. Some people don’t realize they qualify. Others avoid it because of stigma around smoking, or because they assume that since they quit, they’re no longer at risk.
If you’re between 50 and 80, have a significant smoking history, and either still smoke or quit in the last 15 years, annual LDCT screening is one of the highest-impact preventive steps available to you. If you fall outside those criteria but have occupational exposures, high radon levels at home, or a family history of lung cancer, bring those specifics to your doctor so you can make an informed decision together about whether screening is appropriate.